France Menopause Market Size, Share, and COVID-19 Impact Analysis, By Treatment (Dietary Supplements, OTC Pharma Products), By Diagnosis (Women’s Age, Menstrual History, and Symptoms), and France Menopause Market Insights, Industry Trend, Forecasts to 2035

France Menopause Market Insights Forecasts to 2035 

• The France Menopause Market Size was Estimated at USD 461.4 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 5.58% from 2025 to 2035
• The France Menopause Market Size is Expected to Reach USD 838.7 Million by 2035

According to a research report published by Spherical Insights and Consulting, The France Menopause Market Size is anticipated to reach USD 838.7 Million by 2035, growing at a CAGR of 5.58% from 2025 to 2035. This is due to demographic changes and growing awareness of the health and wellness requirements of older women, and the market is anticipated to grow significantly.

Market Overview 

The French menopause market refers to the commercial market for products and services that aim to address the various physiological and psychological changes associated with menopause, which marks the natural end of a woman's reproductive years. This includes biomedical treatments, such as hormone replacement therapy (HRT) and alternative treatments, and encompasses the emerging market for nutritional supplements and lifestyle products targeting menopause symptoms. This can result in a net loss of productivity and quality of life, making treatment extremely important. Helping people through menopause creates a large population pool that could benefit from menopause products, such as dietary supplements and Over-the-Counter (OTC) drugs, to relieve symptoms of menopause, including hot flashes, osteoporosis, night sweats, & vaginal atrophy. Night sweats and hot flashes, together referred to as VMS, are part of the Menopausal Transition (MT) key symptoms. Menopausal symptoms also include mood changes, loss of cognitive focus, and depressive symptoms. Hot flashes are seen in an estimated 80% of females experiencing menopause. These hot flashes are accompanied by temporary chills, feelings of anxiety, sweating, and feelings of heat lasting approximately 1 to 5 minutes. With the larger number of females experiencing the system and large numbers of females with menopausal symptoms, it is expected that the segment will grow.

Report Coverage

This research report categorizes the France menopause market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the France menopause market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the France menopause market. 

Driving Factors

The France menopause market is mainly driven by heightened awareness of women's health issues and an aging population, as well as an increasing demand for personalized treatments. Furthermore, innovations in technology and changing perceptions of menopause are additional driving factors. The increase in physical inactivity in women is expected to enhance the expansion of the menopause market shortly. Physical inactivity is the absence of, or minimal physical activity, which refers to all physical activity, including movement during leisure time, when you are transportation to and from locations, and moving as part of your job. The growing issue of physical inactivity in women during menopause continues to increase the demand for products and services that focus on their menopausal symptoms, health risks, and overall well-being

Restraining Factors

The France menopause market is confronted by challenges such as decreased usage of systemic hormone therapy, anxiety about safety and side effects, and the social stigma of menopause. The market is forecasted to deliver growth, but the above factors present challenges for both companies and individuals in how these navigate this phase of life.

Market Segmentation

The France Menopause Market Share is classified into treatment and diagnosis.

• The dietary supplements segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The France menopause market is segmented by treatment into dietary supplements, OTC pharma products. Among these, the dietary supplements segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period. Women take dietary supplements to help reduce menopausal symptoms like mood swings, insomnia, hot flashes, and night sweats. Furthermore, studies have demonstrated that dietary supplements can help prevent early menopause.

• The women's age segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The France menopause market is segmented by diagnosis into women's age, menstrual history, and symptoms. Among these, the women's age segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. Endometriosis, hormonal infertility, and polycystic ovary syndrome are among the fertility problems that women under 50 are more likely to experience.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the France menopause market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. 

List of Key Companies

• Bayer AG
• Theramex
• Dr. Reddy’s Laboratories Ltd.
• AbbVie, Inc.
• Padagis
• ReNew Life Holdings Corporation
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the France Menopause Market based on the below-mentioned segments:

France Menopause Market, By Treatment                                                             

• Dietary Supplements
• OTC Pharma Products

France Menopause Market, By Diagnosis 

• Women's Age
• Menstrual History
• Symptoms